Inside this article
A useful treatment journal needs more detail than “I tried Rugiet.” The product in this entry is Rugiet Daily Boost: daily tadalafil plus DHEA in a cinnamon chew. Keeping that identity intact lets you distinguish a change in medicine from a change in packaging, service or expectations. The public records provide a starting point; they do not describe your eventual response.
Availability: Public product listing; individual eligibility and current prescription require confirmation.
The exact product
Create a baseline entry before comparing experiences. The distinctive feature of this offer is a hormone-precursor ingredient alongside tadalafil. Write the dispensed name and label details separately from the words in an advertisement. A future change in flavor, strength or ingredients can otherwise disappear behind the same familiar brand name. The fact record below identifies the reviewed listing without recommending a dose or telling you how to administer it.
| Provider | Rugiet |
|---|---|
| Listed active ingredients | Tadalafil + DHEA |
| Dosage form | Compounded daily cinnamon chew |
| Regulatory distinction | Compounded preparation; the finished product is not FDA-approved. |
| Source basis | Rugiet: Daily Boost product information |
Price, supply and payment
The financial entry should record the payment date as well as the price. For Rugiet Daily Boost, the public starting point is Complete product plan price not verified. Keep a copy of the quantity and commitment attached to your own quote. If you later change products, this record helps distinguish a new prescription charge from a scheduled renewal. It also makes unused supply visible instead of treating every allocated dose as a successful treatment occasion.
| Earlier trial | 40 selected men; six months; not a Boost study |
|---|---|
| Later trial | 86 randomized; 79 completed; no significant sexual-function differences |
| Price boundary | Full product-specific plan not verified |
| Different from Hims support product | DHEA is not the zinc/arginine/vitamin formula |
What the research can support
Separate a research note from a personal observation. Here the published evidence concerns a small favorable 1999 DHEA trial and a later trial without significant sexual-function benefit; it leaves applicability of those studies to the exact Boost preparation unresolved. Your experience can be important to a clinician without becoming a controlled comparison. Likewise, a provider survey cannot tell you in advance how you will respond. Record the source and its limits beside the claim so that a memorable headline does not become the entire evidence entry.
| Evidence boundary | a small favorable 1999 DHEA trial and a later trial without significant sexual-function benefit |
|---|---|
| Not established here | applicability of those studies to the exact Boost preparation |
| Clinical and regulatory references | Reiter et al. (1999): DHEA and erectile dysfunction · Morales et al. (2009): androgens and sexual function · MedlinePlus: Tadalafil · FDA: Compounding and the FDA — questions and answers · DailyMed: Tadalafil prescribing information, including section 5.11 · MedlinePlus: Sildenafil |
Safety questions for the prescriber
The medication-history page belongs next to this product entry. Include other ED medicines, nitrates or nitrites, riociguat, blood-pressure treatment and medicines used only occasionally. Add relevant heart, kidney, liver or eye history. Do not experiment with overlaps or changes to isolate a side effect yourself. For a prescription such as Rugiet Daily Boost, an accurate account of what was taken and when is more useful than a guess about the ingredient responsible.
| DHEA | A hormone precursor; different studies do not establish the exact combination’s benefits or suitability. |
|---|
Availability and the actual prescription
Date the access information too. The current documentary finding is: Public product listing; individual eligibility and current prescription require confirmation. A product can remain mentioned online after its enrollment rules change. If an account message differs from an article, save both and ask which applies to the proposed prescription. Do not record a public listing as a completed eligibility decision, and do not mistake a pharmacy dispatch estimate for the whole clinical assessment period.
Refills, changes and cancellation
Keep follow-up entries factual: the original concern, the prescribed product, whether its directions were followed, and the response or unwanted effect. A useful prompt specific to this entry is “What finding supports DHEA in my case, and how will its effects be assessed?” Write down the clinician's answer and the plan for reassessment. Billing notes belong alongside this history but do not replace it; postponing a shipment is not necessarily a medical instruction to stop a treatment.
| Membership | 30- and 90-day membership terms; confirm fees and the complete product invoice. |
|---|---|
| Cancellation terms | Terms specify 72 hours before billing; support mentions 24 hours before processing. |
| Timing distinction | Different deadlines refer to different events; confirm the rule for the selected order. |
| Refund boundary | Processing prevents cancellation; ordinary lack of efficacy, side effects or flavor are not refund grounds. |
| Policy sources | Rugiet: terms and conditions · Rugiet Support: canceling an order or subscription · Rugiet Support: treatment response and refunds · Rugiet Support: membership options and inclusions |
Compare named products
The neighboring reviews are useful for explaining what changed between two offers. Compare a formulation field or payment interval instead of collecting general brand impressions. If you discuss a switch, retain the old entry so the prescriber can see the sequence. Do not translate that sequence into a claim that one product is universally better: symptoms, instructions, concurrent medicines and expectations may have changed as well.
Questions to keep with the offer
A good record includes uncertainty. Mark an unverified current plan or missing study as unverified, rather than filling the space with a testimonial. This entry is based on public documents and is not medically reviewed. We have not obtained Rugiet Daily Boost as patients, inspected the supplied medicine or checked individual outcomes. The purpose is to make the next conversation more precise and the written history easier to use.
| Ask about this formula | What finding supports DHEA in my case, and how will its effects be assessed? |
|---|---|
| Ask about the payment | What are the exact quantity, total due now, renewal amount and notice deadline? |
| Ask about a change | Who confirms the medical instructions, pharmacy order and next account charge? |
When to get urgent help
An erection lasting more than four hours or chest pain requires emergency care. Tell the treating clinician what was taken and when.
Sudden hearing or vision loss needs prompt medical attention. Do not wait for an ordinary account-support reply.
Back to all individual product reviews
The sources behind this page
Public material checked October 7, 2026. Provider pages describe advertised products and terms; they do not independently establish treatment quality.
- Rugiet: Daily Boost product informationProvider product page; tadalafil and DHEA combination
- Reiter et al. (1999): DHEA and erectile dysfunctionPrimary placebo-controlled study, 40 selected men; indexed abstract reviewed
- Morales et al. (2009): androgens and sexual functionPrimary randomized study, 86 men; indexed abstract reviewed; no significant sexual-function benefit
- Rugiet: terms and conditionsProvider policy; 72-hour subscription cancellation notice and refund eligibility
- Rugiet Support: canceling an order or subscriptionProvider support; member portal steps and processing restrictions
- Rugiet Support: treatment response and refundsProvider policy; refund exclusions and 24-hour order-change notice
- Rugiet Support: membership options and inclusionsProvider support; plan intervals, shipping, and consultation fees
- MedlinePlus: TadalafilDrug information; standard tadalafil products
- FDA: Compounding and the FDA — questions and answersGovernment guidance on compounded medications
- DailyMed: Tadalafil prescribing information, including section 5.11Prescribing label; not evidence for the 4Play combination
- MedlinePlus: SildenafilDrug information; standard sildenafil products